Valuation: LifeMD, Inc.

Market Cap 105M 93.4M 86.29M 78.2M 146M 9.93B 149M 1.04B 411M 5.2B 393M 384M 16.4B P/E 2026 *
-4.18x
P/E 2027 * -23.7x
Enterprise Value 105M 93.4M 86.29M 78.2M 146M 9.93B 149M 1.04B 411M 5.2B 393M 384M 16.4B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.43x
Free-Float
84.02%
Yield 2026 *
-
Yield 2027 * -
1 day-1.61%
1 week-8.97%
Current month-26.55%
1 month-30.16%
3 months-44.96%
6 months-53.08%
Current year-37.54%
1 week 2.1
Extreme 2.1
2.39
1 month 2.1
Extreme 2.1
3.06
Current year 2.1
Extreme 2.1
5.38
1 year 2.1
Extreme 2.1
6.44
3 years 2.1
Extreme 2.1
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 43 -
Director of Finance/CFO 58 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 04/09/2014
Chairman 43 11/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
11/8/26 Free

Director

35,000 0.0724%
11/8/26 Free

Director

35,000 0.0724%
11/8/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-8.97%-65.81%-68.07% 103M
-0.89%-2.97%+17.06%+44.97% 250B
-0.89%-0.69%+2.13%+11.48% 162B
+2.49%+6.61%-17.48%+66.89% 154B
-1.33%+2.32%-55.64%-9.40% 66.68B
+0.24%+0.99%-15.19%-10.88% 52.08B
+0.50%+4.40%+11.16%+66.05% 52.22B
-0.31%+3.72%+17.37%+30.08% 51.93B
-1.43%-1.03%+16.10%+56.57% 49.02B
-1.05%+2.95%+26.47%+75.95% 44.76B
Average -0.43%+0.17%-6.38%+26.37% 88.24B
Weighted average by Cap. -0.17%+0.54%+0.99%+37.83%

Financials

2026 *2027 *
Net sales 208M 185M 171M 155M 290M 19.71B 295M 2.06B 816M 10.32B 779M 762M 32.55B 245M 219M 202M 183M 343M 23.27B 349M 2.43B 963M 12.19B 920M 900M 38.44B
Net income -24.81M -22.15M -20.46M -18.54M -34.69M -2.35B -35.27M -246M -97.49M -1.23B -93.09M -91.11M -3.89B -4.54M -4.06M -3.75M -3.4M -6.36M -431M -6.46M -45.12M -17.86M -226M -17.06M -16.69M -713M
Net Debt - -
Projected Income Statement - Annual - LifeMD, Inc.
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
24/10/26 USD 2.135 -1.61% 246,811
22/10/26 USD 2.170 +1.40% 674,289
21/10/26 USD 2.140 -4.68% 628,314
20/10/26 USD 2.245 -0.22% 699,726
19/10/26 USD 2.250 -3.85% 784,413
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - LifeMD, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.170USD
Average target price
8.125USD
Spread / Average Target
+274.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeMD, Inc.
  1. Stock Market
  2. Stocks
  3. LFMD Stock